Standard
Effect of the sodium-glucose cotransporter-2 inhibitor dapagliflozinon platelet aggregation response in Cavalier King Charles Spanielswith and without cardiac disease. / Speitzer, A.; Øgelund, E.; Reimann, Maria Josefine; Møller, Jacob Eifer; Skovsted, G.F.; Lyhne, Mille Kronborg; Verma, S.; Ljungvall, Ingrid; Häggström, J.; Olsen, Lisbeth Høier.
In:
Journal of Veterinary Internal Medicine, Vol. 36, No. 6, 2022, p. 2473.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Speitzer, A, Øgelund, E
, Reimann, MJ, Møller, JE, Skovsted, GF
, Lyhne, MK, Verma, S, Ljungvall, I, Häggström, J
& Olsen, LH 2022, '
Effect of the sodium-glucose cotransporter-2 inhibitor dapagliflozinon platelet aggregation response in Cavalier King Charles Spanielswith and without cardiac disease',
Journal of Veterinary Internal Medicine, vol. 36, no. 6, pp. 2473.
https://doi.org/10.1111/jvim.16559APA
Speitzer, A., Øgelund, E.
, Reimann, M. J., Møller, J. E., Skovsted, G. F.
, Lyhne, M. K., Verma, S., Ljungvall, I., Häggström, J.
, & Olsen, L. H. (2022).
Effect of the sodium-glucose cotransporter-2 inhibitor dapagliflozinon platelet aggregation response in Cavalier King Charles Spanielswith and without cardiac disease.
Journal of Veterinary Internal Medicine,
36(6), 2473.
https://doi.org/10.1111/jvim.16559Vancouver
Speitzer A, Øgelund E
, Reimann MJ, Møller JE, Skovsted GF
, Lyhne MK et al.
Effect of the sodium-glucose cotransporter-2 inhibitor dapagliflozinon platelet aggregation response in Cavalier King Charles Spanielswith and without cardiac disease.
Journal of Veterinary Internal Medicine. 2022;36(6):2473.
https://doi.org/10.1111/jvim.16559Author
Speitzer, A. ; Øgelund, E. ; Reimann, Maria Josefine ; Møller, Jacob Eifer ; Skovsted, G.F. ; Lyhne, Mille Kronborg ; Verma, S. ; Ljungvall, Ingrid ; Häggström, J. ; Olsen, Lisbeth Høier. / Effect of the sodium-glucose cotransporter-2 inhibitor dapagliflozinon platelet aggregation response in Cavalier King Charles Spanielswith and without cardiac disease. In: Journal of Veterinary Internal Medicine. 2022 ; Vol. 36, No. 6. pp. 2473.
Bibtex
@article{1ce2e92c9aad4cf88dab82f5a8a7f91c,
title = "Effect of the sodium-glucose cotransporter-2 inhibitor dapagliflozinon platelet aggregation response in Cavalier King Charles Spanielswith and without cardiac disease",
author = "A. Speitzer and E. {\O}gelund and Reimann, {Maria Josefine} and M{\o}ller, {Jacob Eifer} and G.F. Skovsted and Lyhne, {Mille Kronborg} and S. Verma and Ingrid Ljungvall and J. H{\"a}ggstr{\"o}m and Olsen, {Lisbeth H{\o}ier}",
year = "2022",
doi = "10.1111/jvim.16559",
language = "English",
volume = "36",
pages = "2473",
journal = "Journal of Veterinary Internal Medicine",
issn = "0891-6640",
publisher = "Wiley-Blackwell",
number = "6",
}
RIS
TY - ABST
T1 - Effect of the sodium-glucose cotransporter-2 inhibitor dapagliflozinon platelet aggregation response in Cavalier King Charles Spanielswith and without cardiac disease
AU - Speitzer, A.
AU - Øgelund, E.
AU - Reimann, Maria Josefine
AU - Møller, Jacob Eifer
AU - Skovsted, G.F.
AU - Lyhne, Mille Kronborg
AU - Verma, S.
AU - Ljungvall, Ingrid
AU - Häggström, J.
AU - Olsen, Lisbeth Høier
PY - 2022
Y1 - 2022
U2 - 10.1111/jvim.16559
DO - 10.1111/jvim.16559
M3 - Conference abstract in journal
VL - 36
SP - 2473
JO - Journal of Veterinary Internal Medicine
JF - Journal of Veterinary Internal Medicine
SN - 0891-6640
IS - 6
ER -
